Web Stats Provided By Google Analytics

Friday, April 25, 2014

SYLVANT (siltuximab) Receives FDA Approval to Treat Multicentric...

SYLVANT was not studied in patients with MCD who are HIV positive or HHV-8 positive because SYLVANT did not bind to virally produced interleukin-6 in a nonclinical study.

http://ift.tt/1tK1bCB
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)